Quantcast

Latest Clinical trial Stories

2014-06-16 08:29:32

The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16, 2014 /PRNewswire/ -- A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen,...

2014-06-16 08:28:24

Sub-study will investigate effects of MST-188 on tissue oxygenation in sickle cell disease patients experiencing a vaso-occlusive crisis SAN DIEGO, June 16, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in line with prior guidance, it has initiated patient enrollment in a sub-study within EPIC, its pivotal phase 3 study of MST-188 in sickle cell disease, to investigate and quantify the effect of MST-188 on tissue oxygenation, which will be...

2014-06-16 04:21:36

LUGANO, Switzerland, June 16, 2014 /PRNewswire/ -- ESMO welcomes the adoption of the Clinical Trials Regulation by the EU The European Society for Medical Oncology (ESMO) has welcomed the adoption of the Clinical Trials Regulation [http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2014.158.01.0001.01.ENG ] by the EU, entering into force today. The new framework acknowledges the importance of using data stored for a clinical trial beyond the end of...

2014-06-15 08:20:51

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/hormone_refractory_breast_cancer_global_clinical_trials_review_h1_2014.htmlHormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Hormone Refractory Breast Cancer Global Clinical Trials...

2014-06-14 23:01:01

Hot topics on Wednesday, June 18 SAN DIEGO (PRWEB) June 14, 2014 Patient perspective in clinical trials, efforts of the Food and Drug Administration (FDA) to increase the number of regulators overseas, the emerging practice of risk-based monitoring in clinical trials, and challenges in orphan drug regulation will be discussed Wednesday, June 18, at the DIA 2014 50th Annual Meeting at the San Diego Convention Center. Patient Perspective to Drive Enrollment in Clinical Trials “The...

2014-06-13 16:23:24

HAYWARD, Calif., June 13, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced the appointment of Dr. Philip Sager, MD, FACC, FAHA, FHRS, to its Board of Directors. Dr. Sager is a Fellow of the American College of Cardiology, a Fellow of the American Heart Association and a Fellow of the Heart Rhythm Society. Dr. Sager has served as a Consulting...

2014-06-13 08:24:01

SAN DIEGO, June 13, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the 2014 Wells Fargo Securities Healthcare Conference on Wednesday, June 18, 2014, at 2:25 p.m. Eastern Time (11:25 a.m. Pacific Time), at the InterContinental Hotel in Boston, Massachusetts. A live audio webcast of the presentation will be available under the investors section of Arena's website at www.arenapharm.com. A...

2014-06-12 12:27:16

LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/wilms_tumor_nephroblastoma_global_clinical_trials_review.html Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, "Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1,...

2014-06-12 08:35:19

Research Accepted as Podium Presentation at the American Diabetes Association 74th Scientific Sessions BOWIE, Md., June 12, 2014 /PRNewswire/ -- Inovalon, Inc., a leading technology company providing advanced cloud-based analytics and data-driven solutions to the healthcare industry, today announced a comparative safety research study to be presented at the American Diabetes Association 74(th) Scientific Sessions June 13-17 in San Francisco, California. The study was supported by...

2014-06-12 08:28:44

WCCT Global to Attend the 2014 DIA Meeting in San Diego COSTA MESA, Calif., June 12, 2014 /PRNewswire-iReach/ -- WCCT Global (WCCTG), a Southern California headquartered Full Service Contract Research Organization announced today that the organization will be attending the 2014 DIA meeting in San Diego, California. WCCT Global will be an exhibitor at booth #821. WCCTG will be sharing information about many of the exciting clinical research services the company has both added and...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related